Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | OAT | P04181 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1355407 | 0.84 | TSHR (0.42) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL12166924 | 0.74 | PTPN1 (0.43) | TSHRHSD17B10BLMTHRBLMNA | |
| SCHEMBL12189662 | 0.71 | TSHR (0.34) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL21264412 | 0.71 | TSHR (0.34) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL17993483 | 0.71 | TSHR (0.34) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL24755662 | 0.71 | TSHR (0.34) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL20663373 | 0.71 | TSHR (0.33) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL14754410 | 0.70 | TSHR (0.36) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL21985657 | 0.70 | TSHR (0.43) | TSHRMAPK1HSD17B10OATTDP1 | |
| SCHEMBL13802026 | 0.68 | TSHR (0.32) | TSHRMAPK1HSD17B10OATTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4199119-A1 | ULTRA-THIN PLASMONIC SOLAR CELLS, METHODS FOR THEIR MANUFACTURE AND USE | Peafowl Plasmonics AB (SE) | 2023-06-21 | — | — | EP | disclosed |
| EP-3602645-B1 | ULTRA-THIN PLASMONIC SOLAR CELLS, METHODS FOR THEIR MANUFACTURE AND USE | PEAFOWL PLASMONICS AB (SE) | 2023-06-07 | — | — | EP | disclosed |
| US-11242346-B2 | Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2022-02-08 | — | — | US | disclosed |
| WO-2021226327-A1 | NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2021-11-11 | — | — | WO | disclosed |
| US-20200181147-A1 | MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2020-06-11 | — | — | US | disclosed |
| EP-3309162-A1 | TARGETED CONJUGATES OF PYRROLOBENZODIAZEPINES | Seattle Genetics, Inc. (US) | 2018-04-18 | — | — | EP | disclosed |
| US-5155248-A | Reaction product of dibutyltin oxide with selected aromatic aminocarboxylic acid | RHEIN CHEMIE RHEINAU GMBH (DE) | 1992-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11242346-B2 | Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof | MTOR, RPTOR, RICTOR | TSHR 2388/4885MAPK1 70/4885HSD17B10 1480/4885 |
| US-20200181147-A1 | MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF | MTOR, RPTOR, RICTOR | TSHR 2388/4885MAPK1 70/4885HSD17B10 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.